awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28533896-6303B8A2-F696-43C7-A988-6C017335A83E
Q28533896-6303B8A2-F696-43C7-A988-6C017335A83E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28533896-6303B8A2-F696-43C7-A988-6C017335A83E
Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells
P2860
Q28533896-6303B8A2-F696-43C7-A988-6C017335A83E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28533896-6303B8A2-F696-43C7-A988-6C017335A83E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
33e74863604eb1f7aa5d7f26797d3d5279ff8ca5
P2860
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancer